Transplantation · 2019 · 21 citations · 48 references
Life SciencesImmunologyPathologyCellular ImmunologyImmunoregulationTransplant ImmunologyGraft-versus-host DiseaseInnate Immunity In TransplantationLung TransplantationMammalian ImmunologyPulmonary InflammationTransplant ImmunotherapyFibrotic ChangeGraft-versus-host Disease PathophysiologyInterleukin-17 PathwayLung FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis ProgressionPulmonary Graft-versus-host DiseaseTh17 Responses
BACKGROUND: Chronic pulmonary graft-versus-host disease (cpGVHD) after hematopoietic cell transplant (HCT) manifests as progressive airway and parenchymal lung fibrosis. On the basis of our prior data, mice that undergo allogeneic HCT with Tbet-knockout donors (AlloTbet) have increased lung Th17 cells and IL-17A and develop fibrosis resembling human cpGVHD. The role of IL-17A in posttransplant pulmonary fibrosis remains incompletely understood. We hypothesized that IL-17A is necessary for development of murine cpGVHD in this model. METHODS: AlloTbet mice received weekly intraperitoneal anti-IL-17A or IgG (200 μg/mouse) starting 2 weeks post-HCT and were sacrificed after week 5. Histologic airway and parenchymal fibrosis were semiquantitatively graded in a blinded fashion. Lung cells and proteins were measured by flow cytometry, ELISA, and multicytokine assays. RESULTS: Anti-IL-17A modestly decreased airway and parenchymal lung fibrosis, along with a striking reduction in pulmonary neutrophilia, IL-6, MIP-1α, MIP-1β, CXCL1, and CXCL5 in AlloTbet mice. Additionally, anti-IL-17A decreased CCL2, inflammatory monocytes and macrophages, and Th17 cells. CONCLUSIONS: In the setting of murine AlloHCT with Tbet donors, IL-17A blockade decreases fibrotic features of cpGVHD. This may be mediated by the observed reduction in neutrophils or specific lung monocyte and macrophage populations or alternatively via a direct effect on fibroblasts. Collectively, our results further suggest that anti-IL-17A strategies could prove useful in preventing alloimmune-driven fibrotic lung diseases.
48
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn, Estelle Bettelli, Wenda Gao et al. · Nature · 2007 · 1.8K citations
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Ian Y. R. Adamson, D. H. Bowden · PubMed · 1974 · 484 citations